the wound, and the rapid progression of localized tetanus. The man was unaware that a lapse in tetanus booster regimen could reduce immune status and put him at risk for developing the fatal illness. As with many cases of tetanus, it was not possible to document a primary series or booster immunizations other than the 1984 booster.
Tetanus is not a new disease. Symptoms of tetanus were described by Hippocrates in 360 B.C. Dr. Benjamin Rush postulated a tetanus treatment of "bark and wine and blisters of mercury ointment" in 1787. Another early reference to the "raging disease that baffled the healing art" indicates the lack of diagnostic information and effective treatment available in the 18th century (Leonard, 1800) . Today, tetanus is thought to be as innocuous as the "flu." This is an accurate statement considering the epidemic illness and fatality associated with influenza during the early 1900s and the similar potential for tetanus fatality. Tetanus is a serious complication of inadequate immunization and wound care.
The focus of this article is the role of occupational health nurses in protecting clients' health through routine assessment of primary immunization; booster administration of tetanus toxoid every 10 years; and educational interventions around fastidious wound care, risk factors, immunization schedules, and signs and symptoms of tetanus.
THE ORGANISM
Tetanus is caused by gram positive, spore forming, anaerobic Clostridium tetani bacilli. Botulinum and tetanus toxins are the most virulent toxins known. Drumstick shaped spores may survive for years in some *OHNAC is a national prevention program conducted by the National Institute for Occupational Safety and Health (NIOSH) that has placed public health nurses in rural communities and hospitals in 10 states (California, Georgia, Iowa, Kentucky. Maine, Minnesota, New York, North Carolina, North Dakota, and Ohio) to conduct surveillance of agriculture related illnesses and injuries among farmers and their family members. These surveillance data are used to assist in reducing the risk for occupational illness and injury in agricultural populations. environs and resist boiling and disinfectants. C. tetani neurotoxins are released as single polypeptide chains which are later cleaved to create two disulfide linked fragments. The heavy chain is responsible for cell binding and penetration, and the light chain acts intracellularly. Tetanus toxin potency is due to absolute neurospecificity. The combined action of binding to the neuromuscular junction and entrance via vesicles into the intracellular fluid allows access retroaxonally to the spinal inhibitory intemeurons. Tetanus toxin prevents the release of inhibitory neurotransmitter and results in the spastic paralysis characteristic of tetany (Montecucco, 1993) .
INCIDENCE
Tetanus may present as generalized, neonatal, local, or cephalic. The neonatal form presents as generalized tetanus that develops in infants born to under or nonimmunized mothers or following unsterile procedures during labor and delivery. Of the estimated 1 million tetanus deaths worldwide in 1973, approximately 60% to 90% were due to neonatal presentations of tetanus (U.S. Department of Health and Human Services [USDHHS], 1991). Increased childhood vaccination programs have all but eliminated this form of tetanus in the United States.
Cephalic tetanus is a rare finding in which trismus and impairment of one or more cranial (III, IV, VII, IX, X, XII) nerves follows head injury or ear infection. Onset is characteristically rapid over a few days and mortality is high when there is progression to generalized tetanus.
Localized tetanus is also uncommon; this condition may persist for months or progress to generalized tetanus. Muscle spasm or tetany may be limited to the area surrounding the wound, progress proximally, or resolve without complication.
Tetanus occurrence in the United States has decreased from 560 cases during the first year of reporting in 1947 to 45 cases in 1992 (USDHHS, 1993). One study indicated that tetanus incidence is underreported in a comparison of figures from the Centers for Disease Control and Prevention (CDC) and the National Center for Health Statistics (Sutter, 1990) . Of the 467 cases of tetanus reported to the CDC from 1985 to 1992, 433 occurred in adults (USDHHS, 1993) . In 99 reported cases of tetanus from 1987 to 1988, 94% occurred in persons over 20 years of age, 68% in persons 50 years of age or older, and 6% in persons under 20 years of age (USDHHS, 1991) . One case of neonatal tetanus was reported to the CDC from 1985 to 1991 (USDHHS, 1992a) .
The risk for tetanus in the United States' population 80 years and over is more than 10 times the risk for persons age 20 to 29 (Stein, 1993) . These statistics indicate that mortality increases with age in the United States. In a 1980 to 1990 sample of 117 cases of tetanus, 17% in the 40 to 49 age group died, compared to 50% mortality in the 80 and over group. Eleven percent of these individuals reported a primary series of tetanus toxoid and 31% reported no history of tetanus vaccination (Stein, 1993) . Healthy People 2000 disease prevention strategies focus 628 on infant and childhood immunization and fail to address the incidence of tetanus in individuals over the age of 25 years (USDHHS, 1992b) . The United States has one of the lowest rates of infant mortality due to tetanus in the world as a result of ongoing immunization programs for children, while the rate of adult tetanus remains relatively constant.
Tetanus frequently occurs in partially or non-immunized individuals (Groleau, 1992) . This status is difficult to measure when primary immunization may not be assessed in emergency departments and is not documented when tetanus boosters are administered. A report of tetanus in an 80 year old woman illustrates the need to evaluate tetanus status in all adults (USDHHS, 1991) . She had received no primary immunization nor had she been evaluated for tetanus status in numerous visits for hypertension treatment in primary care.
RISK FACTORS
The tetanus bacillus is widely distributed by resistant spore deposition in contaminated fecal material in soil, animal and human feces, clothing, human intestinal tracts, and house dust. Tetanus has been associated with war injuries, intravenous (IV) drug use, operative procedures (particularly bowel surgery), dental procedures, puerperal sepsis, and septic abortion. C. tetani spores are resistant to oxygen, moisture, and extremes of temperature. Smith (1975) reported the highest concentration of C. tetani in soil in warm areas (33 0 to 37 0 C.) with fertile, black soil and high human and animal populations, and a decreased prevalence in cold and high altitude areas. C. tetani has been isolated in air samples taken from hospital operating rooms, garden soil, and dust on clothing.
Spores require tissue with anaerobic conditions such as that found in tissue necrosis, skin ulcers, abscess, gangrene, or imbedded foreign body. Portals of entry into the body may include traumatic or surgical wound, severed umbilical cord, circumcision, excision, bums, frostbite, ear infection, abortion, administration of illicit IV drugs, tattooing, or piercing of ears and nose. The CDC reports that no associated acute injury is identified in up to 29% of cases of tetanus (Groleau, 1992) . Although the average onset of symptoms is 7 days, incubation periods vary from days to months depending on immune status, hygiene, and type of exposure. Fifteen percent of cases occur within 3 days and 10% after 14 days (Isselbacher, 1994) . Poor prognosis is associated with rapid incubation and progression of symptoms.
HISTORY
A pertinent tetanus history will include: a symptom analysis of recent injury involving a break in the skin; progression of symptoms; tetanus status including primary immunization and decade progression of boosters, as well as the most recent associated symptoms that alleviate or exacerbate tetany; housing situation; occupational risk assessment; military service; age; sex; race; regional climate; recent travel; socioeconomic status; hobbies; and recent life events. The importance of ascertaining tetanus immunization status is further illustrated in the case of Arline vs. St. Elizabeth Hospital (1993) . In this case a family successfully recovered damages from a hospital when an emergency physician failed to administer tetanus prophylaxis following a puncture wound to the foot which resulted in the death of the client due to tetanus.
compliant vascular system produced by arteriolar, capillary, and venous dilation may occur between episodic spasms. The mechanism underlying sudden cardiac arrest is not understood.
PHYSICAL EXAMINATION
Tetanus may be manifest in the generalized, neonatal, local, or cephalic form. Generalized tetanus is the most common, presenting as trismus, neck rigidity, stiffness, dysphagia, restlessness, and reflex spasms. Muscular rigidity progresses from the jaw and facial muscles to the abdomen and extensor muscles of the limbs. Risus sardonicus is a characteristic grimace produced by sustained contraction of the facial muscles and raised eyebrows. Contraction of the back muscles produces opisthotonos. Purulent, occlusive otitis may be the source of tetanus infection (DeSouza, 1992) .
Paroxysmal, violent, painful generalized muscle spasms may cause cyanosis, vertebral or long bone fractures, and detachment of tendons from their insertions. Sustained generalized spasm and secondary diaphragmatic spasm or paralysis threaten respiration. Reflex spasm may occur in response to noise and touch. Seizures are possible in generalized tetanus and may be differentiated from epilepsy by consciousness and the experience of severe pain. Deep tendon reflexes may be hyperreflexive. Dysfunction of the autonomic system presents as labile or sustained hypertension, increased cardiac output, tachycardia disproportionate to core temperature elevation, arrhythmia, hyperpyrexia, diaphoresis, peripheral vasoconstriction, and increase in plasma and urinary catecholamine levels. Bradycardia and hypotension related to the highly
ASSESSMENT
Diagnosis is based on history of injury and inadequate immunization and clinical presentation. There may be no history of injury. C. tetani may be isolated from wound cultures; however, this is an unreliable measure of tetanus as it is frequently not isolated from known tetanus disease while often isolated from wounds not producing tetanus symptoms. A serum anti-tetanus antibody level of 0.01 IU/mL (based on guinea pig trials) has been accepted since 1937 as the necessary protective level (Sneath, 1937) . However, serious cases of tetanus have been documented in individuals with 0.04 to 33 IU/mL (Berger, 1978; Crone, 1992; Passen, 1986) .
Controversy surrounding the appropriate protective anti-tetanus antibody value suggests that these values may not be diagnostically useful until further refined by research. The leukocyte count may be elevated. There may be nonspecific changes on electrocardiogram. Toxoid failure may be suspected in agammaglobulinemia, acute exposure to radiation, immunosuppressive drug therapy, acquired immune deficiency states, carcinoma of the breast, poor toxoid, or inaccurate toxoid history (Furste, 1992) . Differential diagnosis for tetanus findings are listed in Table 1 .
TREATMENT
Following the diagnosis of tetanus, the goals of therapy are to eliminate the source of the toxin, neutral-DECEMBER 1995, VOL. 43, NO.12 Provide relevant information concerning tetanus and possible adverse reaction.
3. Treat all wounds as tetanus prone.
4.
Educate individuals identified as high risk concerning wound care and signs and symptoms of tetanus.
5.
Evaluate the immunization status of all individuals in primary care practice.
6.
Fastidious wound care with debridement of necrosis.
7.
Diagnosis of tetanus requires:
.TIG 3,000 to 6,000 units 1M divided.
.Penicillin, erythromycin, clindamycin, or metronidazol 1M .Td .5 cc 1M site separate from TIG injections.
8.
High risk wounds: burns, frostbite; puncture wounds, deep laceration, crushing; soil, manure, saliva exposure; inadequate wound care.
IM= intramuscular; T1G= tetanus immune globulin.
ize toxin present in the system, prevent muscle spasm, and provide respiratory support if necessary through recovery. Penicillin is the drug of choice to eliminate the vegetative cells that are producing toxin. Clindamycin, erythromycin, or metronidazol may be substituted in penicillin allergic individuals (lsselbacher, 1994; Koda-Kimble, 1992) . Tetanus immune globulin (TIG) 3,000 to 6,000 units intramuscular (1M) (dispensed in 250 IU/mL vials) in divided doses is given to neutralize circulating toxin. TIG is preferred over equine antitoxin due to the reduced frequency of allergic and serum sickness reactions and shorter half life (28 days). TIG neutralizes only circulating toxin and has no effect on intraneural toxin. Therefore, it must be given as soon as possible. Passive immunity does not confer active immunity. Tetanus tox-630 oid (and diphtheria) Td .5 ml 1M should be given simultaneously at a separate site to individuals over the age of 7 years. Information concerning tetanus and side effects should be provided to the client, or guardian in the case of a child, according to the Public Health Service Act of 1992, XXI, section 2114 (Furste, 1992) .
RATIONALE FOR TREATMENT VS. PREVENTION COSTS
Further management of acute tetanus requires stabilizing the client in the emergency department and transfer to an intensive care setting. Treatment focuses on neutralization of systemic toxin, prevention of respiratory complications and muscle spasms, and elimination of the source of toxin through careful wound debridement and excision. Therapy is dependent on severity. The average length of intensive care treatment is 1 month (Groleau, 1992) . Rehabilitation may require additional months, and recovery may be incomplete.
When tetanus occurs, the risk of death is substantial, especially in persons over 65 years of age. Prevention of tetanus through proper immunization-primary series, decade boosters, and wound care-is time and cost effective. Balestra (1993) found 87% to 100% of clients have a protective (0.01 mUde) tetanus antitoxin 1eve115 to 25 years after the primary series. Persons from 25 to 65 years compose a majority of the work force, and it would seem a risky experiment to determine just how far that immunity will carry the individual without tetanus occurrence, considering the minimal cost of tetanus toxoid ($.50 to $1.60 per dose ).
Even multiplied by the millions of Americans to be immunized every 10 years, immunization is cost effective considering the emergency care and hospitalization requiring respirators, drugs, expert nursing care, neurologists, cardiologists, surgeons, respiratory therapists, laboratory analysis, as well as lost wages, productivity, personal and family trauma, inactivity, and months of rehabilitation. Of persons returning to work after contracting tetanus, one study found 13% were out of work less than 1 month, 57% were out of work 1 to 3 months, and 26% were out of work greater than 3 months (Luisto, 1992) . In a previous study (Luisto 1980) , tetanus survivors were found to be at higher risk for subsequent muscular fatigue and cramps, nervousness, decreased mental functioning, difficulties with balance, speech and memory, development of palsies, muscular atrophy, and reduced tendon reflexes. When tetanus occurs, the risk of death is substantial. Treatment for those who survive is costly and time consuming. Survivor quality of life and productivity are significantly reduced.
Prevention of tetanus through proper immunization, primary series, decade boosters, and appropriate wound care is time and cost effective. Balestra's (1993) evaluation of the cost effectiveness of vaccination strategies argues for the use of the primary series and one booster at age 65. The author concludes that the decade strategy is more effective but more costly than the 65 year booster. If this proposal were adopted, the health care community might see what effect the decade boosters have in reducing the prevalence of tetanus in this country. However, moral and professional ethics preclude the implementation of such a study.
IMPLICATIONS FOR OCCUPATIONAL HEALTH NURSING PRACTICE
The role of the primary care nurse focuses on prevention, diagnosis, immediate treatment with TIG, and referral for complications of tetanus.
Tetanus Prevention
Partially immunized and unimmunized adults should receive tetanus toxoid. The initial dose of Td, 0.5 mL 1M is followed by a second 4 to 8 weeks later and a third dose 6 to 12 months following the second. Booster doses are recommended at each decade following the final injection of the primary series (Table 2 ). Tetanus may be prevented by treating all injuries with copious irrigation, removing foreign bodies, and debriding devitalized tissue. CDC tetanus summaries indicate that over two thirds of cases occur in wounds not considered serious enough for the individual to seek medical attention (Groleau, 1992) . Abscesses should be excised and drained.
Barriers
Barriers to higher levels of vaccinations include: missed opportunities to vaccinate during contacts with health care providers for unrelated reasons; lack of comprehensive vaccine delivery systems in the public and private sector; high non-insured client fees for immunizations; and client and provider factors concerning adverse events following vaccination. In contrast, the adherence to vaccination schedules is positively associated with physician or nurse recommendations (USDHHS, 1992a) . Mulhooly (1984) found that only 39% of randomly selected adult members of a health maintenance organization who were eligible to receive tetanus toxoid boosters at no cost had received tetanus toxoid injections during a 10 year period. Primary care provider immunization practices and attitudes vary and may not follow established guidelines (Szilagyi, 1994) . The American College of Emergency Physicians recommends that all emergency clients have a review of their tetanus immunization status (Allen, 1994) . Five percent of reported tetanus occurs in individuals without complete primary immunization. Stair (1989) reported a review of emergency cases in which none of 248 persons treated for wounds were immunized against tetanus. Twenty-two of these had nonprotective antibody levels. Allen (1994) suggested protocols be simplified and all wounds be treated as "tetanus prone." This reasonable and cost effective requirement for fastidious treatment of every wound should be a component of all wound care programs.
Target population
Tetanus poses a substantial risk to United States' residents over the age of 50 years. Nurses can prevent the tetanus at both ends of the age spectrum by administering the primary tetanus prophylaxis to infants or at intake of DECEMBER 1995, VOL. 43, NO.12 any adult with an inadequate history of tetanus immunization. It is imperative that one assess the primary and decade status of all adults. Persons at increased risk include nonimmunized or inadequately immunized individuals, such as immigrants, with a history of inadequate health care; those who work with the soil, manure, or animals; clients with puncture wounds or deep or poorly cleaned lacerations, abrasions, or avulsions; and those who have had surgery. Nurses are the front line in the education of clients concerning risk factors and signs and symptoms of tetanus.
Side Effects
Reactions to tetanus toxoid consist primarily of localized edema and tenderness, fever, and rare anaphylactic reactions. Most adverse reactions occur in individuals with hyper-immunization. Necrotizing granulomatous reactions have been reported at the injection site (Miliauskas, 1993) . These may be hypersensitive reactions associated with the aluminum contents (aluminum hydroxide or aluminum phosphate) of some preparations. Adsorbed vaccines should be given by deep intramuscular injection to reduce the risk of granuloma formation (Wirz, 1990) .
Contraindications
Contraindications to Td toxoid are a history of neurologic sequela or severe hypersensitivity reaction following a previous dose. Pregnant women without completed primary series or who are due for a booster should receive the immunization preferably during the second and third trimesters. There is no evidence implicating Td as a teratogen. TIG should be given in pregnancy only when clearly indicated.
Storage
Td vaccine should be stored at 2°to 10°, although higher temperatures for 3 or fewer days does not reduce potency. Freezing has negative effects on vaccine, particularly diptheria-pertussis-tetanus (DPT).
Nurses in primary care, pediatrics, adult, women's health, occupational health, and geriatrics have the power to reduce the status of tetanus in the United States. Ask the question: When was your last tetanus shot?
